We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.10 | 1.28% | 7.91 | 7.88 | 7.95 | 8.00 | 7.89 | 7.92 | 1,433,488 | 21:31:23 |
From May 2019 to May 2024
By Giulia Petroni
Bayer AG said Tuesday that it has entered into a strategic partnership with service-provider Nuvisan GmbH to create a new research unit specialized in molecule research in Berlin.
The German pharmaceutical-and-chemical company said it would transfer a large part of its Berlin-based molecule research unit to Nuvisan and that the new research center will create around 400 jobs.
The financial terms of the deal weren't disclosed.
Bayer said the transaction is expected to close in mid 2020.
Berlin remains the headquarters of Bayer's pharmaceutical division, the company said.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
February 11, 2020 04:22 ET (09:22 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
